[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Amneal Pharmaceuticals Inc (AMRX)

Amneal Pharmaceuticals Inc (AMRX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 5,704,131
  • Shares Outstanding, K 319,023
  • Annual Sales, $ 3,019 M
  • Annual Income, $ 72,060 K
  • EBIT $ 452 M
  • EBITDA $ 698 M
  • 60-Month Beta 1.27
  • Price/Sales 1.92
  • Price/Cash Flow 11.62
  • Price/Book 175.24

Options Overview Details

View History
  • Implied Volatility 71.29% (+15.02%)
  • Historical Volatility 34.05%
  • IV Percentile 34%
  • IV Rank 39.67%
  • IV High 175.93% on 03/30/26
  • IV Low 2.47% on 09/09/25
  • Expected Move (DTE 10) 0.97 (5.67%)
  • Put/Call Vol Ratio 0.20
  • Today's Volume 6
  • Volume Avg (30-Day) 208
  • Put/Call OI Ratio 0.68
  • Today's Open Interest 5,363
  • Open Int (30-Day) 2,964
  • Expected Range 16.13 to 18.07

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 5 analysts offering recommendations.
Earnings Estimates - Current Qtr 09/30/26
See More
  • Average Estimate $0.26
  • Number of Estimates 1
  • High Estimate $0.26
  • Low Estimate $0.26
  • Prior Year $0.15
  • Growth Rate Est. (year over year) +73.33%

Price Performance

See More
Period Period Low Period High Performance
1-Month
16.58 +3.14%
on 07/14/26
19.26 -11.21%
on 07/29/26
+0.09 (+0.53%)
since 07/10/26
3-Month
11.76 +45.41%
on 05/19/26
19.26 -11.21%
on 07/29/26
+4.32 (+33.80%)
since 05/11/26
52-Week
8.82 +93.88%
on 08/12/25
19.26 -11.21%
on 07/29/26
+8.26 (+93.44%)
since 08/11/25

Most Recent Stories

More News
Amneal Completes Acquisition of Kashiv BioSciences, Creating a Global Biosimilar Leader

Establishes an integrated global platform spanning biosimilar R&D, manufacturing and commercialization  Adds a major long-term growth pillar and extends Amneal’s growth profile into the 2030s ...

AMRX : 17.10 (-4.36%)
1 Healthcare Stock Worth Your Attention and 2 We Ignore

1 Healthcare Stock Worth Your Attention and 2 We Ignore

ACHC : 31.10 (-2.14%)
HIMS : 30.51 (-3.97%)
AMRX : 17.10 (-4.36%)
5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call

5 Insightful Analyst Questions From Amneal’s Q2 Earnings Call

AMRX : 17.10 (-4.36%)
AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX Q2 Deep Dive: Diversified Product Mix and Biosimilars Strategy Shape Guidance

AMRX : 17.10 (-4.36%)
Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

Amneal (NASDAQ:AMRX) Beats Expectations in Strong Q2 CY2026, Stock Jumps 15.9%

AMRX : 17.10 (-4.36%)
Amneal: Q2 Earnings Snapshot

Amneal: Q2 Earnings Snapshot

AMRX : 17.10 (-4.36%)
Amneal Reports Second Quarter 2026 Financial Results

–  Q2 2026 Net Revenue of $796 million ; GAAP Net Income of $58 million ; Diluted Income per Share of $0.18 – – Adjusted EBITDA of $206 million ; Adjusted Diluted EPS of...

AMRX : 17.10 (-4.36%)
Amneal's Biosimilar Bet Gets Its First Real Report Card

Barchart Research What to Expect from AMRX Earnings AMRX Generated July 29, 2026 Current Price $19.10 EPS Estimate $$0.24 Consensus Rating Strong Buy Average Move 3.30% Amneal's Biosimilar Bet Gets Its...

AMRX : 17.10 (-4.36%)
Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

Amneal (AMRX) Reports Q2: Everything You Need To Know Ahead Of Earnings

AMRX : 17.10 (-4.36%)
Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

Spotting Winners: Amneal (NASDAQ:AMRX) And Generic Pharmaceuticals Stocks In Q1

AMRX : 17.10 (-4.36%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 80% Buy with a Average short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

Relative Strength just crossed below 50%. The market is indicating support for a bearish trend.

See More Share

Business Summary

Amneal Pharmaceuticals LLC is an integrated specialty pharmaceutical company. It focused on developing, manufacturing and distributing generic, brand and biosimilar products. The company operates primarily in North America, Asia and Europe. Amneal Pharmaceuticals LLC, formerly known as Impax Laboratories...

See More

Key Turning Points

3rd Resistance Point 18.64
2nd Resistance Point 18.32
1st Resistance Point 17.71
Last Price 17.10
1st Support Level 16.78
2nd Support Level 16.46
3rd Support Level 15.85

See More

52-Week High 19.26
Last Price 17.10
Fibonacci 61.8% 15.27
Fibonacci 50% 14.04
Fibonacci 38.2% 12.81
52-Week Low 8.82

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.